{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:24:08Z","timestamp":1787387048459,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016047","name":"Science Fund of the Republic of Serbia","doi-asserted-by":"publisher","award":["6052315"],"award-info":[{"award-number":["6052315"]}],"id":[{"id":"10.13039\/501100016047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12616-x","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:04:48Z","timestamp":1787385888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMAD4 mRNA expression as a diagnostic biomarker in non-small cell lung cancer"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-7944","authenticated-orcid":false,"given":"Tamara","family":"Babic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Karanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miodrag","family":"Dragoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"issue":"3","key":"12616_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, (in eng). CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"12616_CR2","doi-asserted-by":"publisher","unstructured":"Ganti AK, Klein AB, Cotarla I, Seal B, Chou E Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US, (in eng). JAMA Oncol, 7, 12, pp. 1824\u20131832, Dec 01 2021, https:\/\/doi.org\/10.1001\/jamaoncol.2021.4932","DOI":"10.1001\/jamaoncol.2021.4932"},{"key":"12616_CR3","doi-asserted-by":"publisher","unstructured":"Gasparri R, Sabalic A, Spaggiari L (Nov 23 2023) The Early Diagnosis of Lung Cancer: Critical Gaps in the Discovery of Biomarkers, (in eng). J Clin Med 12(23). https:\/\/doi.org\/10.3390\/jcm12237244","DOI":"10.3390\/jcm12237244"},{"key":"12616_CR4","doi-asserted-by":"publisher","unstructured":"Kenaan N et al (Sep 2024) Advances in early detection of non-small cell lung cancer: A comprehensive review, (in eng). Cancer Med 13:e70156. https:\/\/doi.org\/10.1002\/cam4.70156","DOI":"10.1002\/cam4.70156"},{"key":"12616_CR5","doi-asserted-by":"publisher","unstructured":"Kildisiute G et al (Jan 09 2024) Transcriptional signals of transformation in human cancer, (in eng). Genome Med 16(1):8. https:\/\/doi.org\/10.1186\/s13073-023-01279-z","DOI":"10.1186\/s13073-023-01279-z"},{"key":"12616_CR6","doi-asserted-by":"publisher","unstructured":"Wang Y et al (Apr 2021) SMAD4 mutation correlates with poor prognosis in non-small cell lung cancer, (in eng). Lab Invest 101(4):463\u2013476. https:\/\/doi.org\/10.1038\/s41374-020-00517-x","DOI":"10.1038\/s41374-020-00517-x"},{"key":"12616_CR7","doi-asserted-by":"publisher","unstructured":"Guo X, Li M, Wang X, Pan Y, Li J (2021) Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: an observational cohort study, (in eng), BMC Pulm Med, vol. 21, no. 1, p. 111, Apr 01 https:\/\/doi.org\/10.1186\/s12890-021-01480-z","DOI":"10.1186\/s12890-021-01480-z"},{"key":"12616_CR8","doi-asserted-by":"publisher","unstructured":"Bossuyt PM et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies, (in eng), BMJ, vol. 351, p. h5527, Oct 28 https:\/\/doi.org\/10.1136\/bmj.h5527","DOI":"10.1136\/bmj.h5527"},{"key":"12616_CR9","doi-asserted-by":"publisher","unstructured":"Bankovic J et al (2010) Identification of genes associated with non-small-cell lung cancer promotion and progression, (in eng), Lung Cancer, vol. 67, no. 2, pp. 151-9, Feb https:\/\/doi.org\/10.1016\/j.lungcan.2009.04.010","DOI":"10.1016\/j.lungcan.2009.04.010"},{"key":"12616_CR10","unstructured":"R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (2024) [Online]. Available: https:\/\/www.R-project.org\/"},{"key":"12616_CR11","unstructured":"dplyr: A Grammar of Data Manipulation. (2025) [Online]. Available: https:\/\/dplyr.tidyverse.org"},{"key":"12616_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2. Use R!","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) Data Analysis. ggplot2. Use R! Springer, Cham"},{"key":"12616_CR13","unstructured":"ggpubr: \u2018ggplot2\u2019 Based Publication Ready Plots. (2025) [Online]. Available: https:\/\/rpkgs.datanovia.com\/ggpubr\/"},{"key":"12616_CR14","doi-asserted-by":"publisher","unstructured":"Robin X et al (Mar 17 2011) pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves, (in eng). BMC Bioinformatics 12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77","DOI":"10.1186\/1471-2105-12-77"},{"key":"12616_CR15","unstructured":"A Package for Survival Analysis in R. R package version 3.8-3. (2024) [Online]. Available: https:\/\/CRAN.R-project.org\/package=survival"},{"key":"12616_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"T Therneau","year":"2000","unstructured":"Therneau T, Grambsch P (2000) Modeling Survival Data: Extending the Cox Model. Springer, New York"},{"key":"12616_CR17","unstructured":"Kassambara A, Kosinski M, Biecek P (2024) survminer: Drawing Survival Curves using \u2018ggplot2\u2019. R package version 0.5.0, ed"},{"key":"12616_CR18","doi-asserted-by":"publisher","unstructured":"Arafeh R, Shibue T, Dempster JM, Hahn WC, Vazquez F (Jan 2025) The present and future of the Cancer Dependency Map, (in eng). Nat Rev Cancer 25(1):59\u201373. https:\/\/doi.org\/10.1038\/s41568-024-00763-x","DOI":"10.1038\/s41568-024-00763-x"},{"issue":"2","key":"12616_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7150\/ijbs.23230","volume":"14","author":"M Zhao","year":"2018","unstructured":"Zhao M, Mishra L, Deng CX (2018) The role of TGF-\u03b2\/SMAD4 signaling in cancer, (in eng). Int J Biol Sci 14(2):111\u2013123. https:\/\/doi.org\/10.7150\/ijbs.23230","journal-title":"Int J Biol Sci"},{"key":"12616_CR20","doi-asserted-by":"publisher","unstructured":"Zhang Y, Qian J, Gu C, Yang Y (2021) Alternative splicing and cancer: a systematic review, (in eng), Signal Transduct Target Ther, vol. 6, no. 1, p. 78, Feb 24 https:\/\/doi.org\/10.1038\/s41392-021-00486-7","DOI":"10.1038\/s41392-021-00486-7"},{"key":"12616_CR21","unstructured":"Babic T et al Dysregulation of transcripts SMAD4-209 and SMAD4-213 and their respective promoters in colon cancer cell lines"},{"key":"12616_CR22","doi-asserted-by":"publisher","unstructured":"Yang L, Fan Y, Lu H (2022) Pulmonary Large Cell Neuroendocrine Carcinoma, (in eng), Pathol Oncol Res, vol. 28, p. 1610730. https:\/\/doi.org\/10.3389\/pore.2022.1610730","DOI":"10.3389\/pore.2022.1610730"},{"key":"12616_CR23","doi-asserted-by":"publisher","unstructured":"Haeger SM et al Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors, (in eng), Oncogene, vol. 35, no. 5, pp. 577\u2013586, Feb 04 2016. https:\/\/doi.org\/10.1038\/onc.2015.112","DOI":"10.1038\/onc.2015.112"},{"key":"12616_CR24","doi-asserted-by":"publisher","unstructured":"Tan X et al (2021) Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation, (in eng), Nat Commun, vol. 12, no. 1, p. 4853, Aug 11 https:\/\/doi.org\/10.1038\/s41467-021-24898-9","DOI":"10.1038\/s41467-021-24898-9"},{"key":"12616_CR25","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.2147\/OTT.S247015","volume":"13","author":"R Wan","year":"2020","unstructured":"Wan R, Xu X, Ma L, Chen Y, Tang L, Feng J (2020) Novel Alternatively Spliced Variants of Smad4 Expressed in TGF-\u03b2-Induced EMT Regulating Proliferation and Migration of A549 Cells, (in eng). Onco Targets Ther 13:2203\u20132213. https:\/\/doi.org\/10.2147\/OTT.S247015","journal-title":"Onco Targets Ther"},{"key":"12616_CR26","doi-asserted-by":"publisher","unstructured":"Zeng Y et al (2017) MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo, (in eng), Oncotarget, vol. 8, no. 19, pp. 30817\u201330829, May 09 https:\/\/doi.org\/10.18632\/oncotarget.10339","DOI":"10.18632\/oncotarget.10339"},{"key":"12616_CR27","doi-asserted-by":"publisher","unstructured":"Zhang DT, Shi JG, Liu Y, Jiang HM (2014) The prognostic value of Smad4 mRNA in patients with prostate cancer, (in eng), Tumour Biol, vol. 35, no. 4, pp. 3333-7, Apr https:\/\/doi.org\/10.1007\/s13277-013-1439-y","DOI":"10.1007\/s13277-013-1439-y"},{"issue":"10","key":"12616_CR28","doi-asserted-by":"publisher","first-page":"e110182","DOI":"10.1371\/journal.pone.0110182","volume":"9","author":"Y Du","year":"2014","unstructured":"Du Y et al (2014) Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers, (in eng). PLoS ONE 9(10):e110182. https:\/\/doi.org\/10.1371\/journal.pone.0110182","journal-title":"PLoS ONE"},{"key":"12616_CR29","doi-asserted-by":"publisher","unstructured":"Tan WCC et al (2020) Overview of multiplex immunohistochemistry\/immunofluorescence techniques in the era of cancer immunotherapy, (in eng), Cancer Commun (Lond), vol. 40, no. 4, pp. 135\u2013153, Apr https:\/\/doi.org\/10.1002\/cac2.12023","DOI":"10.1002\/cac2.12023"},{"key":"12616_CR30","doi-asserted-by":"publisher","unstructured":"Li M et al (2025) A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications, (in eng). Int J Cancer Jun 19. https:\/\/doi.org\/10.1002\/ijc.35523","DOI":"10.1002\/ijc.35523"},{"key":"12616_CR31","doi-asserted-by":"publisher","unstructured":"Hernandez AL, Young CD, Wang JH, Wang XJ (2019) Lessons learned from SMAD4 loss in squamous cell carcinomas, (in eng), Mol Carcinog, vol. 58, no. 9, pp. 1648\u20131655, Sep https:\/\/doi.org\/10.1002\/mc.23049","DOI":"10.1002\/mc.23049"},{"key":"12616_CR32","doi-asserted-by":"publisher","unstructured":"Davison JM et al (May 2014) Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms, (in eng). Am J Surg Pathol 38(5):583\u2013592. https:\/\/doi.org\/10.1097\/PAS.0000000000000194","DOI":"10.1097\/PAS.0000000000000194"},{"key":"12616_CR33","doi-asserted-by":"publisher","unstructured":"Liu NN et al (2014) SMAD4 is a potential prognostic marker in human breast carcinomas, (in eng), Tumour Biol, vol. 35, no. 1, pp. 641\u2009\u2013\u200950, Jan https:\/\/doi.org\/10.1007\/s13277-013-1088-1","DOI":"10.1007\/s13277-013-1088-1"},{"key":"12616_CR34","doi-asserted-by":"publisher","unstructured":"Talukdar J et al (Mar 03 2025) Downregulation of SMAD2 and SMAD4 is associated with poor prognosis and shorter survival in esophageal squamous cell carcinoma, (in eng). Mol Biol Rep 52(1):274. https:\/\/doi.org\/10.1007\/s11033-025-10390-w","DOI":"10.1007\/s11033-025-10390-w"},{"key":"12616_CR35","doi-asserted-by":"publisher","unstructured":"Bachet JB et al (2012) Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma, (in eng), Ann Oncol, vol. 23, no. 9, pp. 2327\u20132335, Sep https:\/\/doi.org\/10.1093\/annonc\/mdr617","DOI":"10.1093\/annonc\/mdr617"},{"key":"12616_CR36","doi-asserted-by":"publisher","unstructured":"Provencio M et al (Sep 2025) Biomarker landscape in advanced NSCLC: insights from a national prospective registry, (in eng). Lung Cancer 207:108680. https:\/\/doi.org\/10.1016\/j.lungcan.2025.108680","DOI":"10.1016\/j.lungcan.2025.108680"},{"key":"12616_CR37","doi-asserted-by":"publisher","unstructured":"Odintsov I, Sholl LM (2024) Prognostic and predictive biomarkers in non-small cell lung carcinoma, (in eng), Pathology, vol. 56, no. 2, pp. 192\u2013204, Mar https:\/\/doi.org\/10.1016\/j.pathol.2023.11.006","DOI":"10.1016\/j.pathol.2023.11.006"},{"key":"12616_CR38","doi-asserted-by":"publisher","first-page":"251686572311609","DOI":"10.1177\/25168657231160985","volume":"16","author":"R Cherchi","year":"2023","unstructured":"Cherchi R et al (2023) Next Generation Sequencing for miRNA Detection on the Exhaled Breath Condensate: A Pilot Study, (in eng). Epigenet Insights 16:25168657231160985. https:\/\/doi.org\/10.1177\/25168657231160985","journal-title":"Epigenet Insights"},{"key":"12616_CR39","doi-asserted-by":"publisher","unstructured":"Ferrari PA, Salis CB, Macci\u00f2 A (2025) Current Evidence Supporting the Role of miRNA as a Biomarker for Lung Cancer Diagnosis Through Exhaled Breath Condensate Collection: A Narrative Review, (in eng), Life (Basel), vol. 15, no. 5, Apr 22 https:\/\/doi.org\/10.3390\/life15050683","DOI":"10.3390\/life15050683"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12616-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:04:49Z","timestamp":1787385889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12616-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12616"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12616-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study included paired tumor samples and adjacent normal lung tissue from 49 patients with NSCLC who underwent surgery at the Institute for Lung Diseases, Thoracic Surgery and Tuberculosis, University Clinical Center of Serbia. The study was approved by the Ethics Committee of the University Clinical Center of Serbia under approval number 357\/4 from 30.04.2009. and was carried out according to the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1451"}}